SCHEMBL25868389

SCHEMBL25868389

CC(C)c1cccc(C(C)C)c1N1C(=O)c2ccc3c4ccc5c6c(Oc7ccccc7-c7ccccc7)cc7c8c(cc(Oc9ccccc9-c9ccccc9)c(c9ccc(c%10ccc(c2c3%10)C1=O)c4c59)c86)C(=O)N(c1c(C(C)C)cccc1C(C)C)C7=O

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ANPEP P15144 4/20 0.43
▸ DPP4 P27487 4/20 0.43
▸ NR1H2 P55055 1/20 0.42
▸ NR1H3 Q13133 1/20 0.42
▸ ADRB2 P07550 4/20 0.34
▸ ADRB1 P08588 4/20 0.34
▸ ADRB3 P13945 4/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ KMT2A Q03164 4/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ MEN1 O00255 3/20 0.32
▸ PDCD1 Q15116 1/20 0.32
▸ CD274 Q9NZQ7 1/20 0.32
▸ USP2 O75604 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20048441 0.91 DPP4 (0.48) ANPEPDPP4NR1H2NR1H3ADRB2
SCHEMBL19519619 0.89 ANPEP (0.44) ANPEPDPP4NR1H2NR1H3ADRB2
SCHEMBL24011832 0.88 ANPEP (0.46) ANPEPDPP4NR1H2NR1H3ADRB2
SCHEMBL19519318 0.86 ANPEP (0.39) ANPEPDPP4NR1H2NR1H3ADRB2
SCHEMBL25868446 0.86 ANPEP (0.36) ANPEPDPP4NR1H2NR1H3ADRB2
SCHEMBL25868427 0.85 ANPEP (0.37) ANPEPDPP4NR1H2NR1H3ADRB2
SCHEMBL12482639 0.85 ANPEP (0.48) ANPEPDPP4NR1H2NR1H3ADRB2
SCHEMBL24012109 0.85 ANPEP (0.45) ANPEPDPP4NR1H2NR1H3LMNA
SCHEMBL24011906 0.85 DPP4 (0.43) ANPEPDPP4NR1H2NR1H3ADRB2
SCHEMBL18098677 0.85 ANPEP (0.37) ANPEPDPP4NR1H2NR1H3ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230235217-A1 LUMINESCENT COMPOUND, METHOD FOR PRODUCING LUMINESCENT COMPOUND, LUMINESCENT COMPOSITION, LUMINESCENT THIN FILM AND LUMINESCENT PARTICLES Konica Minolta, Inc. (JP) 2023-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230235217-A1 LUMINESCENT COMPOUND, METHOD FOR PRODUCING LUMINESCENT COMPOUND, LUMINESCENT COMPOSITION, LUMINESCENT THIN FILM AND LUMINESCENT PARTICLES SCLY, SOD1, GPX1 ANPEP 4600/4885DPP4 3835/4885NR1H2 1676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback